Skip to main content

Lymphatic and Tissue Filariasis

  • Chapter
  • First Online:

Abstract

The range and burden of neglected tropical diseases, many of which are helminth-derived, remains enormous. Infections are rampant in poor districts and although efforts have been implemented over the years, there remains insufficient networks for disease control. In India, experts are encouraging the government to develop a functional public health infrastructure to manage diseases. India has 553 million people at risk for lymphatic filariasis (LF), one of the chronic filarial nematode infections that causes severe morbidity in humans. During coevolution, filariae have developed tactics to modulate the host’s immune system so that they can persist for many years. Therefore, most individuals remain asymptomatic and mansonellosis and loiasis are primarily thought of as nuisance infections. Nevertheless, pathology can develop into elephantiasis during LF and Onchocerca volvulus infections can lead to vision loss or skin pathology. Many filarial species require the endosymbiotic Wolbachia bacteria for development and maturation. Indeed, targeting Wolbachia via antibiotic therapy has provided an alternative therapeutic approach which, in contrast to drugs currently employed in mass drug administration programs, is highly macrofilaricidal. This chapter provides an overview about filarial agents drawing upon both their similarities and differences with regards to host immune reactions, ensuing pathologies and how infections alter response to vaccines and other diseases. All of these aspects have to be considered when implementing therapy, especially when adverse side effects may occur. These effects are synopsized in the final section alongside current success stories in terms of elimination and future strategies to control these public health problems.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

ADL:

Acute filarial lymphatic disease

ALB:

Albendazole

CFA:

Circulating filarial antigen

DEC:

Diethylcarbamazine

EN:

Endemic normals

GEO:

Generalized onchocerciasis

Ig:

Immunoglobulin

IVM:

Ivermectin

LF:

Lymphatic filariasis

MDA:

Mass drug administration

Mf:

Microfilaria

SAE:

Serious side effects

TPE:

Tropical pulmonary eosinophilia

References

  • Abiose A (1998) Onchocercal eye disease and the impact of Mectizan treatment. Ann Trop Med Parasitol 92(Suppl 1):S11–22

    CAS  PubMed  Google Scholar 

  • Abraham D, Lucius R, Trees AJ (2002) Immunity to Onchocerca spp. in animal hosts. Trends Parasitol 18:164–171

    CAS  PubMed  Google Scholar 

  • Addiss D (2010) The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: a half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases. Parasit Vectors 3:100

    PubMed Central  PubMed  Google Scholar 

  • Adjobimey T, Hoerauf A (2010) Induction of immunoglobulin G4 in human filariasis: an indicator of immunoregulation. Ann Trop Med Parasitol 104:455–464

    CAS  PubMed Central  PubMed  Google Scholar 

  • Adjobimey T, Satoguina J, Oldenburg J, Hoerauf A, Layland LE (2013) Co-activation through TLR4 and TLR9 but not TLR2 skews Treg-mediated modulation of Igs and induces IL-17 secretion in Treg:B cell co-cultures. Innate Immun 20:12–23

    PubMed  Google Scholar 

  • Adolph PE, Kagan IG, Mc QR (1962) Diagnosis and treatment of Acanthocheilonema perstans filariasis. Am J Trop Med Hyg 11:76–88

    CAS  PubMed  Google Scholar 

  • Akue JP, Devaney E (2002) Transmission intensity affects both antigen-specific and nonspecific T-cell proliferative responses in Loa loa infection. Infect Immun 70:1475–1480

    CAS  PubMed Central  PubMed  Google Scholar 

  • Akue JP, Egwang TG, Devaney E (1994) High levels of parasite-specific IgG4 in the absence of microfilaremia in Loa loa infection. Trop Med Parasitol 45:246–248

    CAS  PubMed  Google Scholar 

  • Akue JP, Devaney E, Wahl G, Moukana H (2002) Expression of filarial-specific IgG subclasses under different transmission intensities in a region endemic for loiasis. Am J Trop Med Hyg 66:245–250

    CAS  PubMed  Google Scholar 

  • Allen JE, Adjei O, Bain O, Hoerauf A, Hoffmann WH, Makepeace BL et al (2008) Of mice, cattle, and humans: the immunology and treatment of river blindness. PLoS Negl Trop Dis 2:e217

    PubMed Central  PubMed  Google Scholar 

  • Almaviva M, Galli M, Rizzi M, Simonelli E, Negri C, Vigevani GM (1984) Immune response in a symptomatic case of Tetrapetalonema perstans infection. Trans R Soc Trop Med Hyg 78:489–491

    CAS  PubMed  Google Scholar 

  • Al-Qaoud KM, Taubert A, Zahner H, Fleischer B, Hoerauf A (1997) Infection of BALB/c mice with the filarial nematode Litomosoides sigmodontis: role of CD4+ T cells in controlling larval development. Infect Immun 65:2457–2461

    CAS  PubMed Central  PubMed  Google Scholar 

  • Al-Qaoud KM, Fleischer B, Hoerauf A (1998) The Xid defect imparts susceptibility to experimental murine filariosis–association with a lack of antibody and IL-10 production by B cells in response to phosphorylcholine. Int Immunol 10:17–25

    CAS  PubMed  Google Scholar 

  • Al-Qaoud KM, Pearlman E, Hartung T, Klukowski J, Fleischer B, Hoerauf A (2000) A new mechanism for IL-5-dependent helminth control: neutrophil accumulation and neutrophil-mediated worm encapsulation in murine filariasis are abolished in the absence of IL-5. Int Immunol 12:899–908

    CAS  PubMed  Google Scholar 

  • Amazigo U (2008) The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 102(Suppl 1):19–22

    PubMed  Google Scholar 

  • Ambroise-Thomas P (1974) Immunological diagnosis of human filariases: present possibilities, difficulties and limitations. Acta Trop 31:108–128

    CAS  PubMed  Google Scholar 

  • Arndts K, Deininger S, Specht S, Klarmann U, Mand S, Adjobimey T et al (2012) Elevated adaptive immune responses are associated with latent infections of Wuchereria bancrofti. PLoS Negl Trop Dis 6:e1611

    CAS  PubMed Central  PubMed  Google Scholar 

  • Asio SM, Simonsen PE, Onapa AW (2009) Analysis of the 24-h microfilarial periodicity of Mansonella perstans. Parasitol Res 104:945–948

    PubMed  Google Scholar 

  • Atmosoedjono S, Partono F, Dennis DT, Purnomo (1977) Anopheles barbirostris (Diptera: Culicidae) as a vector of the timor filaria on Flores Island: preliminary observations. J Med Entomol 13:611–613

    CAS  PubMed  Google Scholar 

  • Attout T, Hoerauf A, Denece G, Debrah AY, Marfo-Debrekyei Y, Boussinesq M et al (2009) Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule. PLoS ONE 4:e8234

    PubMed Central  PubMed  Google Scholar 

  • Awadzi K (2003) Clinical picture and outcome of serious adverse events in the treatment of Onchocerciasis. Filaria J 2(Suppl 1):S6

    PubMed Central  PubMed  Google Scholar 

  • Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT, Lazdins-Helds JK et al (2004a) Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98:359–370

    CAS  PubMed  Google Scholar 

  • Awadzi K, Boakye DA, Edwards G, Opoku NO, Attah SK, Osei-Atweneboana MY et al (2004b) An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98:231–249

    CAS  PubMed  Google Scholar 

  • Babu S, Nutman TB (2003) Proinflammatory cytokines dominate the early immune response to filarial parasites. J Immunol 171:6723–6732

    CAS  PubMed  Google Scholar 

  • Babu S, Ganley LM, Klei TR, Shultz LD, Rajan TV (2000) Role of gamma interferon and interleukin-4 in host defense against the human filarial parasite Brugia malayi. Infect Immun 68:3034–3035

    CAS  PubMed Central  PubMed  Google Scholar 

  • Babu S, Blauvelt CP, Kumaraswami V, Nutman TB (2006) Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence. J Immunol 176:3248–3256

    CAS  PubMed  Google Scholar 

  • Babu S, Bhat SQ, Pavan Kumar N, Lipira AB, Kumar S, Karthik C et al (2009) Filarial lymphedema is characterized by antigen-specific Th1 and th17 proinflammatory responses and a lack of regulatory T cells. PLoS Negl Trop Dis 3:1–9

    Google Scholar 

  • Baird JK, Neafie RC, Connor DH (1988) Nodules in the conjunctiva, bung-eye, and bulge-eye in Africa caused by Mansonella perstans. Am J Trop Med Hyg 38:553–557

    CAS  PubMed  Google Scholar 

  • Baize S, Wahl G, Soboslay PT, Egwang TG, Georges AJ (1997) T helper responsiveness in human Loa loa infection; defective specific proliferation and cytokine production by CD4+ T cells from microfilaraemic subjects compared with amicrofilaraemics. Clin Exp Immunol 108:272–278

    CAS  PubMed Central  PubMed  Google Scholar 

  • Bartholomew CF, Nathan MB, Tikasingh ES (1978) The failure of diethylcarbamazine in the treatment of Mansonella ozzardi infections. Trans R Soc Trop Med Hyg 72:423–424

    CAS  PubMed  Google Scholar 

  • Basanez MG, Pion SD, Churcher TS, Breitling LP, Little MP, Boussinesq M (2006) River blindness: a success story under threat? PLoS Med 3:e371

    PubMed Central  PubMed  Google Scholar 

  • Basanez MG, Pion SD, Boakes E, Filipe JA, Churcher TS, Boussinesq M (2008) Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis 8:310–322

    CAS  PubMed  Google Scholar 

  • Boatin BA, Richards FO Jr (2006) Control of onchocerciasis. Adv Parasitol 61:349–394

    PubMed  Google Scholar 

  • Boatin BA, Toe L, Alley ES, Nagelkerke NJ, Borsboom G, Habbema JD (2002) Detection of Onchocerca volvulus infection in low prevalence areas: a comparison of three diagnostic methods. Parasitology 125:545–552

    CAS  PubMed  Google Scholar 

  • Bockarie MJ, Deb RM (2010) Elimination of lymphatic filariasis: do we have the drugs to complete the job? Curr Opin Infect Dis 23:617–620

    CAS  PubMed  Google Scholar 

  • Borsboom GJ, Boatin BA, Nagelkerke NJ, Agoua H, Akpoboua KL, Alley EW et al (2003) Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa. Filaria J 2:8

    PubMed Central  PubMed  Google Scholar 

  • Boussinesq M (2012) Loiasis: new epidemiologic insights and proposed treatment strategy. J Travel Med 19:140–143

    PubMed  Google Scholar 

  • Bouvet JP, Therizol M, Auquier L (1977) Microfilarial polyarthritis in a massive Loa loa infestation. A case report. Acta Trop 34:281–284

    CAS  PubMed  Google Scholar 

  • Brattig NW, Buttner DW, Hoerauf A (2001) Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria. Microbes Infect 3:439–446

    CAS  PubMed  Google Scholar 

  • Brattig NW, Schwohl A, Hoerauf A, Buttner DW (2009) Identification of the lipid mediator prostaglandin E2 in tissue immune cells of humans infected with the filaria Onchocerca volvulus. Acta Trop 112:231–235

    CAS  PubMed  Google Scholar 

  • Bregani ER, Ceraldi T, Rovellini A, Ghiringhelli C (2002) Case report: intraocular localization of Mansonella perstans in a patient from south Chad. Trans R Soc Trop Med Hyg 96:654

    PubMed  Google Scholar 

  • Brockington IF, Olsen EG, Goodwin JF (1967) Endomyocardial fibrosis in Europeans resident in tropical Africa. Lancet 1:583–588

    CAS  PubMed  Google Scholar 

  • Brown M, Kizza M, Watera C, Quigley MA, Rowland S, Hughes P et al (2004) Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. J Infect Dis 190:1869–1879

    PubMed  Google Scholar 

  • Brumpt EJA (1904) La Filaria loa, Guyot, est la forme adulte de la microfilaire désignée sous le nom de Filaria diurna Manson. Comp Rend Soc Biol Paris 56:630

    Google Scholar 

  • Budge PJ, Little KM, Mues KE, Kennedy ED, Prakash A, Rout J et al (2013) Impact of community-based lymphedema management on perceived disability among patients with lymphatic filariasis in Orissa State, India. PLoS Negl Trop Dis 7:e2100

    PubMed Central  PubMed  Google Scholar 

  • Burchard GD, Kern P (1987) Failure of high dose mebendazole as a microfilaricide in patients with loiasis. Trans R Soc Trop Med Hyg 81:420

    CAS  PubMed  Google Scholar 

  • Burri H, Loutan L, Kumaraswami V, Vijayasekaran V (1996) Skin changes in chronic lymphatic filariasis. Trans R Soc Trop Med Hyg 90:671–674

    CAS  PubMed  Google Scholar 

  • Büttner DW, Wanji S, Bazzocchi C, Bain O, Fischer P (2003) Obligatory symbiotic Wolbachia endobacteria are absent from Loa loa. Filaria J 2:10

    PubMed Central  PubMed  Google Scholar 

  • Cambanis A (2010) Pulmonary loiasis and HIV coinfection in rural Cameroon. PLoS Negl Trop Dis 4:e572

    PubMed Central  PubMed  Google Scholar 

  • Cao WC, Van der Ploeg CP, Plaisier AP, van der Sluijs IJ, Habbema JD (1997) Ivermectin for the chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment. Trop Med Int Health 2:393–403

    CAS  PubMed  Google Scholar 

  • Casiraghi M, Favia G, Cancrini G, Bartoloni A, Bandi C (2001) Molecular identification of Wolbachia from the filarial nematode Mansonella ozzardi. Parasitol Res 87:417–420

    CAS  PubMed  Google Scholar 

  • Cerqueira N (1959) Sobbre a transmissao da Mansonella ozzardi. Jornal Brasileiro de Medicina (Rio) 1:885–914

    Google Scholar 

  • Chadee DD, Tilluckdharry CC, Rawlins SC, Doon R, Nathan MB (1995) Mass chemotherapy with diethylcarbamazine for the control of Bancroftian filariasis: a twelve-year follow-up in northern Trinidad, including observations on Mansonella ozzardi. Am J Trop Med Hyg 52:174–176

    CAS  PubMed  Google Scholar 

  • Chadee DD, Rawlins SC, Tiwari TS (2003) Short communication: concomitant malaria and filariasis infections in Georgetown, Guyana. Trop Med Int Health 8:140–143

    PubMed  Google Scholar 

  • Chijioke CP, Okonkwo PO (1992) Adverse events following mass ivermectin therapy for onchocerciasis. Trans R Soc Trop Med Hyg 86:284–246

    CAS  PubMed  Google Scholar 

  • Chitkara RK, Krishna G (2006) Parasitic pulmonary eosinophilia. Semin Respir Crit Care Med 27:171–184

    PubMed  Google Scholar 

  • Chu BK, Hooper PJ, Bradley MH, McFarland DA, Ottesen EA (2010) The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000–2007). PLoS Negl Trop Dis 4:e708

    PubMed Central  PubMed  Google Scholar 

  • Coffeng LE, Stolk WA, Zoure HG, Veerman JL, Agblewonu KB, Murdoch ME et al (2013) African Programme for Onchocerciasis Control 1995–2015: model-estimated health impact and cost. PLoS Negl Trop Dis 7:e2032

    PubMed Central  PubMed  Google Scholar 

  • Cooper PJ, Espinel I, Paredes W, Guderian RH, Nutman TB (1998) Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J Infect Dis 178:1133–1138

    CAS  PubMed  Google Scholar 

  • Coulibaly YI, Dembele B, Diallo AA, Lipner EM, Doumbia SS, Coulibaly SY et al (2009) A randomized trial of doxycycline for Mansonella perstans infection. N Engl J Med 361:1448–1458

    CAS  PubMed Central  PubMed  Google Scholar 

  • Cully DF, Vassilatis DK, Liu KK, Paress PS, Van der Ploeg LH, Schaeffer JM et al (1994) Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 371:707–711

    CAS  PubMed  Google Scholar 

  • Dadzie Y, Neira M, Hopkins D (2003) Final report of the conference on the eradicability of Onchocerciasis. Filaria J 2:2

    PubMed Central  PubMed  Google Scholar 

  • Daniels CW (1898) Discovery of the parental form of a British Guiana blood worm. Br Med J 1:1011–1012

    CAS  PubMed Central  PubMed  Google Scholar 

  • Das BK, Sahoo PK, Ravindran B (1996) A role for tumour necrosis factor-alpha in acute lymphatic filariasis. Parasite Immunol 18:421–424

    CAS  PubMed  Google Scholar 

  • de Kraker ME, Stolk WA, van Oortmarssen GJ, Habbema JD (2006) Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti. Trop Med Int Health 11:718–728

    PubMed  Google Scholar 

  • Debrah AY, Mand S, Specht S, Marfo-Debrekyei Y, Batsa L, Pfarr K et al (2006) Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog 2:0829–0843

    CAS  Google Scholar 

  • Debrah AY, Mand S, Toliat MR, Marfo-Debrekyei Y, Batsa L, Nurnberg P et al (2007) Plasma vascular endothelial growth Factor-A (VEGF-A) and VEGF-A gene polymorphism are associated with hydrocele development in lymphatic filariasis. Am J Trop Med Hyg 77:601–608

    CAS  PubMed  Google Scholar 

  • Debrah AY, Batsa L, Albers A, Mand S, Toliat MR, Nurnberg P et al (2011a) Transforming growth factor-beta1 variant Leu10Pro is associated with both lack of microfilariae and differential microfilarial loads in the blood of persons infected with lymphatic filariasis. Hum Immunol 72:1143–1148

    CAS  PubMed  Google Scholar 

  • Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Albers A, Specht S et al (2011b) Macrofilaricidal activity in Wuchereria bancrofti after 2 weeks treatment with a combination of rifampicin plus doxycycline. J Parasitol Res 2011; 201617

    Google Scholar 

  • Delaporte F (2008) The discovery of the vector of Robles disease. Parassitologia 50:227–231

    CAS  PubMed  Google Scholar 

  • Desjardins CA, Cerqueira GC, Goldberg JM, Hotopp JC, Haas BJ, Zucker J et al (2013) Genomics of Loa loa, a Wolbachia-free filarial parasite of humans. Nat Genet 45:495–500

    CAS  PubMed  Google Scholar 

  • Diawara L, Traore MO, Badji A, Bissan Y, Doumbia K, Goita SF et al (2009) Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 3:e497

    PubMed Central  PubMed  Google Scholar 

  • Dimock KA, Eberhard ML, Lammie PJ (1996) Th1-like antifilarial immune responses predominate in antigen-negative persons. Infect Immun 64:2962–2967

    CAS  PubMed Central  PubMed  Google Scholar 

  • Doetze A, Satoguina J, Burchard G, Rau T, Loliger C, Fleischer B et al (2000) Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int Immunol 12:623–630

    CAS  PubMed  Google Scholar 

  • Dreyer G, Amaral F, Noroes J, Medeiros Z (1994) Ultrasonographic evidence for stability of adult worm location in bancroftian filariasis. Trans R Soc Trop Med Hyg 88:558

    CAS  PubMed  Google Scholar 

  • Dreyer G, Medeiros Z, Netto MJ, Leal NC, de Castro LG, Piessens WF (1999) Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans R Soc Trop Med Hyg 93:413–417

    CAS  PubMed  Google Scholar 

  • Dreyer G, Noroes J, Figueredo-Silva J, Piessens WF (2000) Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitol Today 16:544–548

    CAS  PubMed  Google Scholar 

  • Ducorps M, Gardon-Wendel N, Ranque S, Ndong W, Boussinesq M, Gardon J et al (1995) Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin. Bull Soc Pathol Exot 88:105–112

    CAS  PubMed  Google Scholar 

  • Duke BO (1954) The uptake of the microfilariae of Acanthocheilonema streptocerca by Culicoides grahamii, and their subsequent development. Ann Trop Med Parasitol 48:416–420

    CAS  PubMed  Google Scholar 

  • Duke BO (1957) Experimental transmission of Loa loa from man to monkey. Nature 179:1357–1358

    CAS  PubMed  Google Scholar 

  • Duke BO, Zea-Flores G, Munoz B (1991) The embryogenesis of Onchocerca volvulus over the first year after a single dose of ivermectin. Trop Med Parasitol 42:175–180

    CAS  PubMed  Google Scholar 

  • Dukes DC, Gelfand M, Gadd KG, Clarke VD, Goldsmid JM (1968) Cerebral filariasis caused by Acanthocheilonema perstans. Cent Afr J Med 14:21–27

    CAS  PubMed  Google Scholar 

  • Eberhard ML, Lammie PJ (1991) Laboratory diagnosis of filariasis. Clin Lab Med 11:977–1010

    CAS  PubMed  Google Scholar 

  • Eberhard ML, Hightower AW, Addiss DG, Lammie PJ (1997) Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin. Am J Trop Med Hyg 57:483–486

    CAS  PubMed  Google Scholar 

  • Elias D, Britton S, Kassu A, Akuffo H (2007) Chronic helminth infections may negatively influence immunity against tuberculosis and other diseases of public health importance. Expert Rev Anti Infect Ther 5:475–484

    PubMed  Google Scholar 

  • Elias D, Britton S, Aseffa A, Engers H, Akuffo H (2008) Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine 26:3897–3902

    CAS  PubMed  Google Scholar 

  • Eveland LK, Yermakov V, Kenney M (1975) Loa loa infection without microfilaraemia. Trans R Soc Trop Med Hyg 69:354–355

    CAS  PubMed  Google Scholar 

  • Fain A (1978) Current problems of loaiasis. Bull World Health Organ 56:155–167

    CAS  PubMed Central  PubMed  Google Scholar 

  • Fernandez Ruiz D, Dubben B, Saeftel M, Endl E, Deininger S, Hoerauf A et al (2009) Filarial infection induces protection against P. berghei liver stages in mice. Microbes Infect 11:172–180

    CAS  PubMed  Google Scholar 

  • Fink DL, Kamgno J, Nutman TB (2011) Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia. PLoS Negl Trop Dis 5:e1299

    CAS  PubMed Central  PubMed  Google Scholar 

  • Fischer P, Kipp W, Kabwa P, Buttner DW (1995) Onchocerciasis and human immunodeficiency virus in western Uganda: prevalences and treatment with ivermectin. Am J Trop Med Hyg 53:171–178

    CAS  PubMed  Google Scholar 

  • Fischer P, Bamuhiiga J, Buttner DW (1997) Occurrence and diagnosis of Mansonella streptocerca in Uganda. Acta Trop 63:43–55

    CAS  PubMed  Google Scholar 

  • Fischer P, Tukesiga E, Buttner DW (1999) Long-term suppression of Mansonella streptocerca microfilariae after treatment with ivermectin. J Infect Dis 180:1403–1405

    CAS  PubMed  Google Scholar 

  • Foster DG (1956) Filariasis, a rare cause of pericarditis. J Trop Med Hyg 59:212–214

    CAS  PubMed  Google Scholar 

  • Freedman DO, de Almeida Filho PJ, Besh S, Maia e Silva MC, Braga C, Maciel A (1994) Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis. J Infect Dis 170:927–933

    CAS  PubMed  Google Scholar 

  • Freedman DO, Bui T, De Almeida Filho PJ, Braga C, Maia e Silva MC, Maciel A et al (1995) Lymphoscintigraphic assessment of the effect of diethylcarbamazine treatment on lymphatic damage in human bancroftian filariasis. Am J Trop Med Hyg 52:258–261

    CAS  PubMed  Google Scholar 

  • Gallin M, Edmonds K, Ellner JJ, Erttmann KD, White AT, Newland HS et al (1988) Cell-mediated immune responses in human infection with Onchocerca volvulus. J Immunol 140:1999–2007

    CAS  PubMed  Google Scholar 

  • Garcia A, Abel L, Cot M, Richard P, Ranque S, Feingold J et al (1999) Genetic epidemiology of host predisposition microfilaraemia in human loiasis. Trop Med Int Health 4:565–574

    CAS  PubMed  Google Scholar 

  • Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M (1997) Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350:18–22

    CAS  PubMed  Google Scholar 

  • Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga N, Duke BO (2002) Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet 360:203–210

    CAS  PubMed  Google Scholar 

  • Gelfand M, Wessels P (1964) Acanthocheilonema perstans in a European female. A discussion of its possible pathogenicity and a suggested new syndrome. Trans R Soc Trop Med Hyg 58:552–526

    CAS  PubMed  Google Scholar 

  • Gentilini M, Carme B (1981) Treatment of filariases in a hospital setting. Complications – results. Ann Soc Belg Med Trop 61:319–326

    CAS  PubMed  Google Scholar 

  • Globisch D, Moreno AY, Hixon MS, Nunes AA, Denery JR, Specht S et al (2013) Onchocerca volvulus-neurotransmitter tyramine is a biomarker for river blindness. Proc Natl Acad Sci U S A 110:4218–4223

    CAS  PubMed Central  PubMed  Google Scholar 

  • Graham AL, Lamb TJ, Read AF, Allen JE (2005) Malaria-filaria coinfection in mice makes malarial disease more severe unless filarial infection achieves patency. J Infect Dis 191:410–421

    PubMed  Google Scholar 

  • Greene BM, Taylor HR, Cupp EW, Murphy RP, White AT, Aziz MA et al (1985) Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Engl J Med 313:133–138

    CAS  PubMed  Google Scholar 

  • Grobusch MP, Kombila M, Autenrieth I, Mehlhorn H, Kremsner PG (2003) No evidence of Wolbachia endosymbiosis with Loa loa and Mansonella perstans. Parasitol Res 90:405–408

    CAS  PubMed  Google Scholar 

  • Grove DI (1990) A history of human helminthology. Bookcraft (Bath) Ltd, Bath, UK

    Google Scholar 

  • Guderian RH, Proano R, Beck B, Mackenzie CD (1987) The reduction in microfilariae loads in the skin and eye after nodulectomy in Ecuadorian onchocerciasis. Trop Med Parasitol 38:275–278

    CAS  PubMed  Google Scholar 

  • Haapasalo K, Meri T, Jokiranta TS (2009) Loa loa Microfilariae evade complement attack in vivo by acquiring regulatory proteins from host plasma. Infect Immun 77:3886–3893

    CAS  PubMed Central  PubMed  Google Scholar 

  • Haarbrink M, Terhell AJ, Abadi K, Asri M, de Medeiros F, Yazdanbakhsh M (1999) Anti-filarial IgG4 in men and women living in Brugia malayi-endemic areas. Trop Med Int Health 4:93–97

    CAS  PubMed  Google Scholar 

  • Habermann RT, Menges RW (1968) Filariasis (Acanthocheilonema perstans) in a gorilla. Vet Med Small Anim Clin 63:1040–1043

    CAS  PubMed  Google Scholar 

  • Hawking F (1981) Chemotherapy of filariasis. Antibiot Chemother 30:135–162

    CAS  PubMed  Google Scholar 

  • Higazi TB, Zarroug IM, Mohamed HA, Elmubark WA, Deran TC, Aziz N et al (2013) Interruption of Onchocerca volvulus transmission in the Abu Hamed Focus, Sudan. Am J Trop Med Hyg 89:51–57

    PubMed  Google Scholar 

  • Hoerauf A (2008) Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis. Curr Opin Infect Dis 21:673–681

    CAS  PubMed  Google Scholar 

  • Hoerauf A (2009) Mansonella perstans–the importance of an endosymbiont. N Engl J Med 361:1502–1504

    CAS  PubMed  Google Scholar 

  • Hoerauf A (2011) Onchocerciasis. In: Guerrant RL, Walker DH, Weller PF (eds) Tropical infectious diseases: principles, pathogens and practice, 3rd edn. Saunders Elsevier, Philadelphia, pp 741–749

    Google Scholar 

  • Hoerauf A, Brattig N (2002) Resistance and susceptibility in human onchocerciasis–beyond Th1 vs. Th2. Trends Parasitol 18:25–31

    CAS  PubMed  Google Scholar 

  • Hoerauf A, Nissen-Pahle K, Schmetz C, Henkle-Duhrsen K, Blaxter ML, Buttner DW et al (1999) Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility. J Clin Invest 103:11–8

    CAS  PubMed Central  PubMed  Google Scholar 

  • Hoerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth IB, Fleischer B et al (2000) Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 355:1242–1243

    CAS  PubMed  Google Scholar 

  • Hoerauf A, Kruse S, Brattig NW, Heinzmann A, Mueller-Myhsok B, Deichmann KA (2002) The variant Arg110Gln of human IL-13 is associated with an immunologically hyper-reactive form of onchocerciasis (sowda). Microbes Infect 4:37–42

    CAS  PubMed  Google Scholar 

  • Hoerauf A, Satoguina J, Saeftel M, Specht S (2005) Immunomodulation by filarial nematodes. Parasite Immunol 27:417–429

    CAS  PubMed  Google Scholar 

  • Hoerauf A, Specht S, Buttner M, Pfarr K, Mand S, Fimmers R et al (2008) Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. Med Microbiol Immunol 197:295–311

    CAS  PubMed Central  PubMed  Google Scholar 

  • Hoerauf A, Specht S, Marfo-Debrekyei Y, Buttner M, Debrah AY, Mand S et al (2009) Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus. Parasitol Res 104:437–447

    PubMed  Google Scholar 

  • Hoerauf A, Pfarr K, Mand S, Debrah AY, Specht S (2011) Filariasis in Africa–treatment challenges and prospects. Clin Microbiol Infect 17:977–985

    CAS  PubMed  Google Scholar 

  • Holmes GK, Gelfand M, Boyt W, Mackenzie P (1969) A study to investigate the pathogenicity of a parasite resembling Acanthocheilonema perstans. Trans R Soc Trop Med Hyg 63:479–484

    CAS  PubMed  Google Scholar 

  • Hotez PJ, Dumonteil E, Heffernan MJ, Bottazzi ME (2013) Innovation for the ‘bottom 100 million’: eliminating neglected tropical diseases in the Americas. Adv Exp Med Biol 764:1–12

    CAS  PubMed  Google Scholar 

  • Hübner MP, Stocker JT, Mitre E (2009) Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunology 127:512–522

    PubMed Central  PubMed  Google Scholar 

  • Hübner MP, Shi Y, Torrero MN, Mueller E, Larson D, Soloviova K et al (2012) Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-beta. J Immunol 188:559–568

    PubMed Central  PubMed  Google Scholar 

  • Hussain R, Hamilton RG, Kumaraswami V, Adkinson NF Jr, Ottesen EA (1981) IgE responses in human filariasis. I. Quantitation of filaria-specific IgE. J Immunol 127:1623–1629

    CAS  PubMed  Google Scholar 

  • Jungmann P, Figueredo-Silva J, Dreyer G (1991) Bancroftian lymphadenopathy: a histopathologic study of fifty-eight cases from northeastern Brazil. Am J Trop Med Hyg 45:325–331

    CAS  PubMed  Google Scholar 

  • Kamgno J, Gardon J, Gardon-Wendel N, Demanga N, Duke BO, Boussinesq M (2004) Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly. Trans R Soc Trop Med Hyg 98:496–504

    CAS  PubMed  Google Scholar 

  • Kamgno J, Pion SD, Mackenzie CD, Thylefors B, Boussinesq M (2009) Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events. Am J Trop Med Hyg 81:1056–1061

    CAS  PubMed  Google Scholar 

  • Keiser PB, Nutman TB (2002) Update on lymphatic filarial infections. Curr Infect Dis Rep 4:65–69

    PubMed  Google Scholar 

  • Keiser PB, Coulibaly Y, Kubofcik J, Diallo AA, Klion AD, Traore SF et al (2008) Molecular identification of Wolbachia from the filarial nematode Mansonella perstans. Mol Biochem Parasitol 160:123–128

    CAS  PubMed Central  PubMed  Google Scholar 

  • Kerr TS (1904) Calabar swelling and its relationship to Filaria loa and diurna. J Trop Med Hyg 7:195

    Google Scholar 

  • Kilian HD (1988) The use of a topical Mazzotti test in the diagnosis of onchocerciasis. Trop Med Parasitol 39:235–238

    CAS  PubMed  Google Scholar 

  • Kilian HD, Nielsen G (1989a) Cell-mediated and humoral immune response to tetanus vaccinations in onchocerciasis patients. Trop Med Parasitol 40:285–291

    CAS  PubMed  Google Scholar 

  • Kilian HD, Nielsen G (1989b) Cell-mediated and humoral immune responses to BCG and rubella vaccinations and to recall antigens in onchocerciasis patients. Trop Med Parasitol 40:445–453

    CAS  PubMed  Google Scholar 

  • King CL, Nutman TB (1991) Regulation of the immune response in lymphatic filariasis and onchocerciasis. Immunol Today 12:A54–58

    CAS  PubMed  Google Scholar 

  • King CL, Kumaraswami V, Poindexter RW, Kumari S, Jayaraman K, Alling DW et al (1992) Immunologic tolerance in lymphatic filariasis. Diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic state. J Clin Invest 89:1403–1410

    CAS  PubMed Central  PubMed  Google Scholar 

  • King CL, Mahanty S, Kumaraswami V, Abrams JS, Regunathan J, Jayaraman K et al (1993) Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest 92:1667–1673

    CAS  PubMed Central  PubMed  Google Scholar 

  • Kipp W, Bamhuhiiga J (2002) Onchodermal skin disease in a hyperendemic onchocerciasis focus in western Uganda. Am J Trop Med Hyg 67:475–479

    PubMed  Google Scholar 

  • Kipp W, Bamuhiiga J, Rubaale T (2003) Simulium neavei-transmitted onchocerciasis: HIV infection increases severity of onchocercal skin disease in a small sample of patients. Trans R Soc Trop Med Hyg 97:310–311

    PubMed  Google Scholar 

  • Klion AD, Nutman TB (2011) Loiasis and Mansonella Infections. In: Guerrant RL, Walker DH, Weller PF (eds) Tropical infectious diseases: principles, pathogens and practice, 3rd edn. Saunders Elsevier, Philadelphia, pp 735–740

    Google Scholar 

  • Klion AD, Massougbodji A, Sadeler BC, Ottesen EA, Nutman TB (1991) Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. J Infect Dis 163:1318–1325

    CAS  PubMed  Google Scholar 

  • Klion AD, Eisenstein EM, Smirniotopoulos TT, Neumann MP, Nutman TB (1992) Pulmonary involvement in loiasis. Am Rev Respir Dis 145:961–963

    CAS  PubMed  Google Scholar 

  • Klion AD, Massougbodji A, Horton J, Ekoue S, Lanmasso T, Ahouissou NL et al (1993) Albendazole in human loiasis: results of a double-blind, placebo-controlled trial. J Infect Dis 168:202–206

    CAS  PubMed  Google Scholar 

  • Klion AD, Ottesen EA, Nutman TB (1994) Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up. J Infect Dis 169:604–610

    CAS  PubMed  Google Scholar 

  • Klion AD, Vijaykumar A, Oei T, Martin B, Nutman TB (2003) Serum immunoglobulin G4 antibodies to the recombinant antigen, Ll-SXP-1, are highly specific for Loa loa infection. J Infect Dis 187:128–133

    CAS  PubMed  Google Scholar 

  • Kluxen G, Hoerauf A (2008) The significance of some observations on African ocular onchocerciasis described by Jean Hissette (1888–1965). Bull Soc Belge Ophtalmol 307:53–58

    PubMed  Google Scholar 

  • Korten S, Buttner DW, Schmetz C, Hoerauf A, Mand S, Brattig N (2009) The nematode parasite Onchocerca volvulus generates the transforming growth factor-beta (TGF-beta). Parasitol Res 105:731–741

    PubMed  Google Scholar 

  • Korten S, Kaifi JT, Buttner DW, Hoerauf A (2010) Transforming growth factor-beta expression by host cells is elicited locally by the filarial nematode Onchocerca volvulus in hyporeactive patients independently from Wolbachia. Microbes Infect 12:555–564

    CAS  PubMed  Google Scholar 

  • Korten S, Hoerauf A, Kaifi JT, Buttner DW (2011) Low levels of transforming growth factor-beta (TGF-beta) and reduced suppression of Th2-mediated inflammation in hyperreactive human onchocerciasis. Parasitology 138:35–45

    CAS  PubMed Central  PubMed  Google Scholar 

  • Kumaraswami V (2000) The clinical manifestations of lymphatic filariasis. In: Nutman TB (ed) Lymphatic filariasis. Imperial College Press, London, UK

    Google Scholar 

  • Kurniawan A, Yazdanbakhsh M, van Ree R, Aalberse R, Selkirk ME, Partono F et al (1993) Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis. J Immunol 150:3941–3950

    CAS  PubMed  Google Scholar 

  • Lange AM, Yutanawiboonchai W, Scott P, Abraham D (1994) IL-4- and IL-5-dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice. J Immunol 153:205–211

    CAS  PubMed  Google Scholar 

  • Leichsenring M, Troger J, Nelle M, Buttner DW, Darge K, Doehring-Schwerdtfeger E (1990) Ultrasonographical investigations of onchocerciasis in Liberia. Am J Trop Med Hyg 43:380–385

    CAS  PubMed  Google Scholar 

  • Lipner EM, Gopi PG, Subramani R, Kolappan C, Sadacharam K, Kumaran P et al (2006) Coincident filarial, intestinal helminth, and mycobacterial infection: helminths fail to influence tuberculin reactivity, but BCG influences hookworm prevalence. Am J Trop Med Hyg 74:841–847

    PubMed  Google Scholar 

  • Lobos E, Nutman TB, Hothersall JS, Moncada S (2003) Elevated immunoglobulin E against recombinant Brugia malayi gamma-glutamyl transpeptidase in patients with bancroftian filariasis: association with tropical pulmonary eosinophilia or putative immunity. Infect Immun 71:747–753

    CAS  PubMed Central  PubMed  Google Scholar 

  • Lustigman S, James ER, Tawe W, Abraham D (2002) Towards a recombinant antigen vaccine against Onchocerca volvulus. Trends Parasitol 18:135–141

    CAS  PubMed  Google Scholar 

  • Mackenzie CD, Homeida MM, Hopkins AD, Lawrence JC (2012) Elimination of onchocerciasis from Africa: possible? Trends Parasitol 28:16–22

    PubMed  Google Scholar 

  • Mahanty S, Nutman TB (1995) Immunoregulation in human lymphatic filariasis: the role of interleukin 10. Parasite Immunol 17:385–392

    CAS  PubMed  Google Scholar 

  • Mahanty S, Mollis SN, Ravichandran M, Abrams JS, Kumaraswami V, Jayaraman K et al (1996) High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis 173:769–773

    CAS  PubMed  Google Scholar 

  • Mand S, Marfo-Debrekyei Y, Dittrich M, Fischer K, Adjei O, Hoerauf A (2003) Animated documentation of the filaria dance sign (FDS) in bancroftian filariasis. Filaria J 2:3

    PubMed Central  PubMed  Google Scholar 

  • Mand S, Marfo-Debrekyei Y, Debrah A, Buettner M, Batsa L, Pfarr K et al (2005) Frequent detection of worm movements in onchocercal nodules by ultrasonography. Filaria J 4:1

    PubMed Central  PubMed  Google Scholar 

  • Mand S, Supali T, Djuardi J, Kar S, Ravindran B, Hoerauf A (2006) Detection of adult Brugia malayi filariae by ultrasonography in humans in India and Indonesia. Trop Med Int Health 11:1375–1381

    CAS  PubMed  Google Scholar 

  • Mand S, Pfarr K, Sahoo PK, Satapathy AK, Specht S, Klarmann U et al (2009) Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine. Am J Trop Med Hyg 81:702–711

    CAS  PubMed  Google Scholar 

  • Mand S, Debrah AY, Klarmann U, Batsa L, Marfo-Debrekyei Y, Kwarteng A et al (2012) Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial. Clin Infect Dis 55:621–630

    CAS  PubMed Central  PubMed  Google Scholar 

  • Manguin S, Bangs MJ, Pothikasikorn J, Chareonviriyaphap T (2010) Review on global co-transmission of human Plasmodium species and Wuchereria bancrofti by Anopheles mosquitoes. Infect Genet Evol 10:159–177

    CAS  PubMed  Google Scholar 

  • Manoury B, Gregory WF, Maizels RM, Watts C (2001) Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Curr Biol 11:447–451

    CAS  PubMed  Google Scholar 

  • Manson P (1891) The sleeping sickness of Central Africa and Filaria sanguinis hominis minor

    Google Scholar 

  • Manson P (1897) On certain new species of nematode haematozoa occurring in America. Br Med J 1837

    Google Scholar 

  • Manson P (1899) Parental form of filaria perstans. Br Med J 1:429

    Google Scholar 

  • Marinkelle CJ, German E (1970) Mansonelliasis in the Comisaria del Vaupes of Colombia. Trop Geogr Med 22:101–11

    CAS  PubMed  Google Scholar 

  • Martin C, Le Goff L, Ungeheuer MN, Vuong PN, Bain O (2000) Drastic reduction of a filarial infection in eosinophilic interleukin-5 transgenic mice. Infect Immun 68:3651–3656

    CAS  PubMed Central  PubMed  Google Scholar 

  • Martin-Prevel Y, Cosnefroy JY, Tshipamba P, Ngari P, Chodakewitz JA, Pinder M (1993) Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis. Am J Trop Med Hyg 48:186–192

    CAS  PubMed  Google Scholar 

  • McNeeley DF, Raccurt CP, Boncy J, Lowrie RC Jr (1989) Clinical evaluation of Mansonella ozzardi in Haiti. Trop Med Parasitol 40:107–110

    CAS  PubMed  Google Scholar 

  • Meyers WM, Connor DH, Harman LE, Fleshman K, Moris R, Neafie RC (1972) Human streptocerciasis. A clinico-pathologic study of 40 Africans (Zairians) including identification of the adult filaria. Am J Trop Med Hyg 21:528–545

    CAS  PubMed  Google Scholar 

  • Meyers WM, Moris R, Neafie RC, Connor DH, Bourland J (1978) Streptocerciasis: degeneration of adult Dipetalonema streptocerca in man following diethylcarbamazine therapy. Am J Trop Med Hyg 27:1137–1147

    CAS  PubMed  Google Scholar 

  • Michael E, Bundy DA, Grenfell BT (1996) Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 112:409–428

    PubMed  Google Scholar 

  • Mitre E, Chien D, Nutman TB (2008) CD4(+) (and not CD25+) T cells are the predominant interleukin-10-producing cells in the circulation of filaria-infected patients. J Infect Dis 197:94–101

    PubMed  Google Scholar 

  • MMWR (2013) Progress toward elimination of onchocerciasis in the Americas - 1993–2012. MMWR Morb Mortal Wkly Rep 62:405–408

    Google Scholar 

  • Molina MA, Cabezas MT, Gimenez MJ (1999) Mansonella perstans filariasis in a HIV patient: finding in bone marrow. Haematologica 84:861

    CAS  PubMed  Google Scholar 

  • Molyneux DH, Bradley M, Hoerauf A, Kyelem D, Taylor MJ (2003) Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol 19:516–522

    CAS  PubMed  Google Scholar 

  • Mongin (1770) Observation on a worm found under conjunctiva in Maribou, Saint Domingue Island. J Med Chir Pharm Paris 32; 338

    Google Scholar 

  • Morales-Hojas R, Post RJ, Shelley AJ, Maia-Herzog M, Coscaron S, Cheke RA (2001) Characterisation of nuclear ribosomal DNA sequences from Onchocerca volvulus and Mansonella ozzardi (Nematoda: Filarioidea) and development of a PCR-based method for their detection in skin biopsies. Int J Parasitol 31:169–177

    CAS  PubMed  Google Scholar 

  • Moreno Y, Nabhan JF, Solomon J, Mackenzie CD, Geary TG (2010) Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi. Proc Natl Acad Sci U S A 107:20120–20125

    CAS  PubMed Central  PubMed  Google Scholar 

  • Murdoch ME, Hay RJ, Mackenzie CD, Williams JF, Ghalib HW, Cousens S et al (1993) A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br J Dermatol 129:260–269

    CAS  PubMed  Google Scholar 

  • Murdoch ME, Asuzu MC, Hagan M, Makunde WH, Ngoumou P, Ogbuagu KF et al (2002) Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Ann Trop Med Parasitol 96:283–296

    CAS  PubMed  Google Scholar 

  • Neafie RC, Connor DH, Meyers WM (1975) Dipetalonema streptocerca (Macfie and Corson, 1922): description of the adult female. Am J Trop Med Hyg 24:264–267

    CAS  PubMed  Google Scholar 

  • Nelson GS (1991) Human onchocerciasis: notes on the history, the parasite and the life cycle. Ann Trop Med Parasitol 85:83–95

    CAS  PubMed  Google Scholar 

  • Nielsen NO, Simonsen PE, Dalgaard P, Krarup H, Magnussen P, Magesa S et al (2007) Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial. Am J Trop Med Hyg 77:507–513

    PubMed  Google Scholar 

  • Noireau F, Apembet JD, Nzoulani A, Carme B (1990) Clinical manifestations of loiasis in an endemic area in the Congo. Trop Med Parasitol 41:37–39

    CAS  PubMed  Google Scholar 

  • Numasaki M, Lotze MT, Sasaki H (2004) Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts. Immunol Lett 93:39–43

    CAS  PubMed  Google Scholar 

  • Nutman TB, Kazura JW (2011) Lymphatic filariasis. In: Guerrant RL, Walker DH, Weller PF (eds) Tropical infectious diseases: principles, pathogens and practice, 3rd edn. Saunders Elsevier, Philadelelphia, PA, pp 729–734

    Google Scholar 

  • Nutman TB, Kradin RL (2002) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-2002. A 24-year-old woman with paresthesias and muscle cramps after a stay in Africa. N Engl J Med 346:115–122

    PubMed  Google Scholar 

  • Nutman TB, Kumaraswami V (2001) Regulation of the immune response in lymphatic filariasis: perspectives on acute and chronic infection with Wuchereria bancrofti in South India. Parasite Immunol 23:389–399

    CAS  PubMed  Google Scholar 

  • Nutman TB, Miller KD, Mulligan M, Ottesen EA (1986) Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations. J Infect Dis 154:10–18

    CAS  PubMed  Google Scholar 

  • Nutman TB, Kumaraswami V, Ottesen EA (1987a) Parasite-specific anergy in human filariasis. Insights after analysis of parasite antigen-driven lymphokine production. J Clin Invest 79:1516–1523

    CAS  PubMed Central  PubMed  Google Scholar 

  • Nutman TB, Nash TE, Ottesen EA (1987b) Ivermectin in the successful treatment of a patient with Mansonella ozzardi infection. J Infect Dis 156:662–665

    CAS  PubMed  Google Scholar 

  • Nutman TB, Reese W, Poindexter RW, Ottesen EA (1988) Immunologic correlates of the hyperresponsive syndrome of loiasis. J Infect Dis 157:544–550

    CAS  PubMed  Google Scholar 

  • Nutman TB, Parredes W, Kubofcik J, Guderian RH (1996) Polymerase chain reaction-based assessment after macrofilaricidal therapy in Onchocerca volvulus infection. J Infect Dis 173:773–776

    CAS  PubMed  Google Scholar 

  • Orihel TC (1984) The tail of the Mansonella streptocerca microfilaria. Am J Trop Med Hyg 33:1278

    CAS  PubMed  Google Scholar 

  • Osei-Atweneboana MY, Awadzi K, Attah SK, Boakye DA, Gyapong JO, Prichard RK (2011) Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl Trop Dis 5:e998

    PubMed Central  PubMed  Google Scholar 

  • Otsuji Y (2011) History, epidemiology and control of filariasis. Trop Med Health 39:3–13

    PubMed Central  PubMed  Google Scholar 

  • Ottesen EA (2008) Immunopathology of lymphatic filariasis in man. Springer Semin Immunopathol 2:373–385

    Google Scholar 

  • Ottesen EA, Weller PF, Heck L (1977) Specific cellular immune unresponsiveness in human filariasis. Immunology 33:413–421

    CAS  PubMed Central  PubMed  Google Scholar 

  • Ottesen EA, Weller PF, Lunde MN, Hussain R (1982) Endemic filariasis on a Pacific Island. II. Immunologic aspects: immunoglobulin, complement, and specific antifilarial IgG, IgM, and IgE antibodies. Am J Trop Med Hyg 31:953–961

    CAS  PubMed  Google Scholar 

  • Ottesen EA, Skvaril F, Tripathy SP, Poindexter RW, Hussain R (1985) Prominence of IgG4 in the IgG antibody response to human filariasis. J Immunol 134:2707–2712

    CAS  PubMed  Google Scholar 

  • Ottesen EA, Hooper PJ, Bradley M, Biswas G (2008) The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis 2:e317

    PubMed Central  PubMed  Google Scholar 

  • Pacque M, Munoz B, Greene BM, Taylor HR (1991) Community-based treatment of onchocerciasis with ivermectin: safety, efficacy, and acceptability of yearly treatment. J Infect Dis 163:381–385

    CAS  PubMed  Google Scholar 

  • Paleologo FP, Neafie RC, Connor DH (1984) Lymphadenitis caused by Loa loa. Am J Trop Med Hyg 33:395–402

    CAS  PubMed  Google Scholar 

  • Palumbo E (2008) Filariasis: diagnosis, treatment and prevention. Acta Biomed 79:106–109

    CAS  PubMed  Google Scholar 

  • Parkhouse RM, Bofill M, Gomez-Priego A, Janossy G (1985) Human macrophages and T-lymphocyte subsets infiltrating nodules of Onchocerca volvulus. Clin Exp Immunol 62:13–18

    CAS  PubMed Central  PubMed  Google Scholar 

  • Pearlman E, Gillette-Ferguson I (2007) Onchocerca volvulus, Wolbachia and river blindness. Chem Immunol Allergy 92:254–265

    CAS  PubMed  Google Scholar 

  • Peel E (1946) Filariids of chimpanzees Pan paniscus and Pan satyrus in Belgian Congo. Ann Soc Belg Med Trop 26:117

    Google Scholar 

  • Petersen HH, Nielsen NO, Monrad J, Magesa SM, Simonsen PE (2009) The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine in Wuchereria bancrofti infected individuals. Parasitol Int 58:141–144

    CAS  PubMed  Google Scholar 

  • Pfarr KM, Debrah AY, Specht S, Hoerauf A (2009) Filariasis and lymphoedema. Parasite Immunol 31:664–672

    CAS  PubMed Central  PubMed  Google Scholar 

  • Pilotte N, Torres M, Tomaino FR, Laney SJ, Williams SA (2013) A TaqMan-based multiplex real-time PCR assay for the simultaneous detection of Wuchereria bancrofti and Brugia malayi. Mol Biochem Parasitol 189:33–37

    CAS  PubMed  Google Scholar 

  • Prost A, Nebout M, Rougemont A (1979) Lepromatous leprosy and onchocerciasis. Br Med J 1:589–590

    CAS  PubMed Central  PubMed  Google Scholar 

  • Ramachandran CP (1981) The epidemiology and control of Brugian filariasis in South East Asia: an update. Ann Soc Belg Med Trop 61:257–268

    CAS  PubMed  Google Scholar 

  • Rao RU, Moussa H, Weil GJ (2002) Brugia malayi: effects of antibacterial agents on larval viability and development in vitro. Exp Parasitol 101:77–81

    CAS  PubMed  Google Scholar 

  • Ravindran B, Satapathy AK, Sahoo PK, Mohanty MC (2003) Protective immunity in human lymphatic filariasis: problems and prospects. Med Microbiol Immunol 192:41–46

    PubMed  Google Scholar 

  • Rebollo MP, Bockarie MJ (2013) Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame. Expert Rev Anti Infect Ther 11:723–731

    CAS  PubMed  Google Scholar 

  • Ristimaki A, Narko K, Enholm B, Joukov V, Alitalo K (1998) Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273:8413–8418

    CAS  PubMed  Google Scholar 

  • Rougemont A, Boisson-Pontal ME, Pontal PG, Gridel F, Sangare S (1977) Tuberculin skin tests and B.C.G. vaccination in hyperendemic area of onchocerciasis. Lancet 1:309

    CAS  PubMed  Google Scholar 

  • Saeftel M, Volkmann L, Korten S, Brattig N, Al-Qaoud K, Fleischer B et al (2001) Lack of interferon-gamma confers impaired neutrophil granulocyte function and imparts prolonged survival of adult filarial worms in murine filariasis. Microbes Infect 3:203–213

    CAS  PubMed  Google Scholar 

  • Saint Andre A, Blackwell NM, Hall LR, Hoerauf A, Brattig NW, Volkmann L et al (2002) The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 295:1892–1895

    CAS  PubMed  Google Scholar 

  • Samykutty A, Dakshinamoorthy G, Kalyanasundaram R (2010) Multivalent vaccine for lymphatic filariasis. Procedia Vaccinol 3:12–18

    CAS  PubMed Central  PubMed  Google Scholar 

  • Satapathy AK, Sartono E, Sahoo PK, Dentener MA, Michael E, Yazdanbakhsh M et al (2006) Human bancroftian filariasis: immunological markers of morbidity and infection. Microbes Infect 8:2414–2423

    CAS  PubMed  Google Scholar 

  • Satoguina J, Mempel M, Larbi J, Badusche M, Loliger C, Adjei O et al (2002) Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect 4:1291–1300

    CAS  PubMed  Google Scholar 

  • Satoguina JS, Weyand E, Larbi J, Hoerauf A (2005) T regulatory-1 cells induce IgG4 production by B cells: role of IL-10. J Immunol 174:4718–4726

    CAS  PubMed  Google Scholar 

  • Satoguina JS, Adjobimey T, Arndts K, Hoch J, Oldenburg J, Layland LE et al (2008) Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta. Eur J Immunol 38:3101–3113

    CAS  PubMed  Google Scholar 

  • Sauerbrey M (2008) The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol 102(Suppl 1):25–29

    PubMed  Google Scholar 

  • Schonemeyer A, Lucius R, Sonnenburg B, Brattig N, Sabat R, Schilling K et al (2001) Modulation of human T cell responses and macrophage functions by onchocystatin, a secreted protein of the filarial nematode Onchocerca volvulus. J Immunol 167:3207–3215

    CAS  PubMed  Google Scholar 

  • Semnani RT, Nutman TB (2004) Toward an understanding of the interaction between filarial parasites and host antigen-presenting cells. Immunol Rev 201:127–138

    CAS  PubMed  Google Scholar 

  • Semnani RT, Sabzevari H, Iyer R, Nutman TB (2001) Filarial antigens impair the function of human dendritic cells during differentiation. Infect Immun 69:5813–5822

    CAS  PubMed Central  PubMed  Google Scholar 

  • Semnani RT, Liu AY, Sabzevari H, Kubofcik J, Zhou J, Gilden JK et al (2003) Brugia malayi microfilariae induce cell death in human dendritic cells, inhibit their ability to make IL-12 and IL-10, and reduce their capacity to activate CD4+ T cells. J Immunol 171:1950–1960

    CAS  PubMed  Google Scholar 

  • Semnani RT, Law M, Kubofcik J, Nutman TB (2004) Filaria-induced immune evasion: suppression by the infective stage of Brugia malayi at the earliest host-parasite interface. J Immunol 172:6229–6238

    CAS  PubMed  Google Scholar 

  • Sentongo E, Rubaale T, Buttner DW, Brattig NW (1998) T cell responses in coinfection with Onchocerca volvulus and the human immunodeficiency virus type 1. Parasite Immunol 20:431–439

    CAS  PubMed  Google Scholar 

  • Shenoy RK (2008) Clinical and pathological aspects of filarial lymphedema and its management. Korean J Parasitol 46:119–125

    CAS  PubMed Central  PubMed  Google Scholar 

  • Shenoy RK, George LM, John A, Suma TK, Kumaraswami V (1998) Treatment of microfilaraemia in asymptomatic brugian filariasis: the efficacy and safety of the combination of single doses of ivermectin and diethylcarbamazine. Ann Trop Med Parasitol 92:579–585

    CAS  PubMed  Google Scholar 

  • Shenoy RK, John A, Hameed S, Suma TK, Kumaraswami V (2000) Apparent failure of ultrasonography to detect adult worms of Brugia malayi. Ann Trop Med Parasitol 94:77–82

    CAS  PubMed  Google Scholar 

  • Simonsen PE (2009) Filariasis. Manson’s tropical diseases: expert consult basic, 22e. In: Cook GC, Zumla A (eds) Philadelphia: Saunders, Elsevier. Section 11:1477–1513

    Google Scholar 

  • Simonsen PE, Dunyo SK (1999) Comparative evaluation of three new tools for diagnosis of bancroftian filariasis based on detection of specific circulating antigens. Trans R Soc Trop Med Hyg 93:278–282

    CAS  PubMed  Google Scholar 

  • Simonsen PE, Mwakitalu ME (2013) Urban lymphatic filariasis. Parasitol Res 112:35–44

    PubMed Central  PubMed  Google Scholar 

  • Simonsen PE, Onapa AW, Asio SM (2011) Mansonella perstans filariasis in Africa. Acta Trop 120(Suppl 1):S109–120

    PubMed  Google Scholar 

  • Smith HL, Rajan TV (2000) Tetracycline inhibits development of the infective-stage larvae of filarial nematodes in vitro. Exp Parasitol 95:265–270

    CAS  PubMed  Google Scholar 

  • Soboslay PT, Dreweck CM, Hoffmann WH, Luder CG, Heuschkel C, Gorgen H et al (1992) Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment. Clin Exp Immunol 89:407–413

    CAS  PubMed Central  PubMed  Google Scholar 

  • Soboslay PT, Geiger SM, Weiss N, Banla M, Luder CG, Dreweck CM et al (1997) The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection. Immunology 90:592–599

    CAS  PubMed Central  PubMed  Google Scholar 

  • Soboslay PT, Luder CG, Riesch S, Geiger SM, Banla M, Batchassi E et al (1999) Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls. Immunology 97:219–225

    CAS  PubMed Central  PubMed  Google Scholar 

  • Sondergaard J (1972) Filariasis caused by Acanthocheilonema perstans. Arch Dermatol 106:547–548

    CAS  PubMed  Google Scholar 

  • Specht S, Saeftel M, Arndt M, Endl E, Dubben B, Lee NA et al (2006) Lack of eosinophil peroxidase or major basic protein impairs defense against murine filarial infection. Infect Immun 74:5236–5243

    CAS  PubMed Central  PubMed  Google Scholar 

  • Specht S, Mand S, Marfo-Debrekyei Y, Debrah AY, Konadu P, Adjei O et al (2008) Efficacy of 2- and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus. Parasitol Res 103:1303–1309

    PubMed  Google Scholar 

  • Specht S, Ruiz DF, Dubben B, Deininger S, Hoerauf A (2010) Filaria-induced IL-10 suppresses murine cerebral malaria. Microbes Infect 12:635–642

    CAS  PubMed  Google Scholar 

  • Steel C, Lujan-Trangay A, Gonzalez-Peralta C, Zea-Flores G, Nutman TB (1991) Immunologic responses to repeated ivermectin treatment in patients with onchocerciasis. J Infect Dis 164:581–587

    CAS  PubMed  Google Scholar 

  • Steel C, Guinea A, McCarthy JS, Ottesen EA (1994) Long-term effect of prenatal exposure to maternal microfilaraemia on immune responsiveness to filarial parasite antigens. Lancet 343:890–893

    CAS  PubMed  Google Scholar 

  • Steel C, Guinea A, Ottesen EA (1996) Evidence for protective immunity to bancroftian filariasis in the Cook Islands. J Infect Dis 174:598–605

    CAS  PubMed  Google Scholar 

  • Stoll NR (1999) This wormy world. 1947. J Parasitol 85:392–396

    CAS  PubMed  Google Scholar 

  • Suma TK, Shenoy RK, Varghese J, Kuttikkal VV, Kumaraswami V (1997) Estimation of ASO titer as an indicator of streptococcal infection precipitating acute adenolymphangitis in brugian lymphatic filariasis. Southeast Asian J Trop Med Public Health 28:826–830

    CAS  PubMed  Google Scholar 

  • Takougang I, Meremikwu M, Wandji S, Yenshu EV, Aripko B, Lamlenn SB et al (2002) Rapid assessment method for prevalence and intensity of Loa loa infection. Bull World Health Organ 80:852–858

    PubMed Central  PubMed  Google Scholar 

  • Talaat KR, Kumarasamy N, Swaminathan S, Gopinath R, Nutman TB (2008) Filarial/human immunodeficiency virus coinfection in urban southern India. Am J Trop Med Hyg 79:558–560

    PubMed Central  PubMed  Google Scholar 

  • Tamarozzi F, Halliday A, Gentil K, Hoerauf A, Pearlman E, Taylor MJ (2011) Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment. Clin Microbiol Rev 24:459–468

    CAS  PubMed Central  PubMed  Google Scholar 

  • Tan KR, Magill AJ, Parise ME, Arguin PM (2011) Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg 84:517–531

    PubMed Central  PubMed  Google Scholar 

  • Tawill SA, Gallin M, Erttmann KD, Kipp W, Bamuhiiga J, Buttner DW (1996) Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seropositive onchocerciasis patients. Trans R Soc Trop Med Hyg 90:85–89

    CAS  PubMed  Google Scholar 

  • Taylor HR (1992) Mazzotti test for onchocerciasis. Lancet 339:1549–1550

    CAS  PubMed  Google Scholar 

  • Taylor MJ, Bandi C, Hoerauf A (2005) Wolbachia bacterial endosymbionts of filarial nematodes. Adv Parasitol 60:245–284

    PubMed  Google Scholar 

  • Taylor MJ, Awadzi K, Basanez MG, Biritwum N, Boakye D, Boatin B et al (2009) Onchocerciasis control: vision for the future from a Ghanian perspective. Parasit Vectors 2:7

    PubMed Central  PubMed  Google Scholar 

  • Taylor MJ, Hoerauf A, Bockarie M (2010) Lymphatic filariasis and onchocerciasis. Lancet 376:1175–1185

    PubMed  Google Scholar 

  • Taylor MJ, Hoerauf A, Townson S, Slatko BE, Ward SA (2013) Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis. Parasitology 18:1–9

    Google Scholar 

  • Tchakoute VL, Graham SP, Jensen SA, Makepeace BL, Nfon CK, Njongmeta LM et al (2006) In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination. Proc Natl Acad Sci U S A 103:5971–2976

    CAS  PubMed Central  PubMed  Google Scholar 

  • Tendongfor N, Wanji S, Ngwa JC, Esum ME, Specht S, Enyong P et al (2012) The human parasite Loa loa in cytokine and cytokine receptor gene knock out BALB/c mice: survival, development and localization. Parasit Vectors 5:43

    CAS  PubMed Central  PubMed  Google Scholar 

  • Theodorides J (1994) Former observations of urinary bilharziasis and wuchereriosis. Bull Soc Pathol Exot 87:191–193

    CAS  PubMed  Google Scholar 

  • Tielsch JM, Beeche A (2004) Impact of ivermectin on illness and disability associated with onchocerciasis. Trop Med Int Health 9:A45–56

    CAS  PubMed  Google Scholar 

  • Timmann C, Fuchs S, Thoma C, Lepping B, Brattig NW, Sievertsen J et al (2004) Promoter haplotypes of the interleukin-10 gene influence proliferation of peripheral blood cells in response to helminth antigen. Genes Immun 5:256–260

    CAS  PubMed  Google Scholar 

  • Turner P, Copeman B, Gerisi D, Speare R (1993) A comparison of the Og4C3 antigen capture ELISA, the Knott test, an IgG4 assay and clinical signs, in the diagnosis of Bancroftian filariasis. Trop Med Parasitol 44:45–48

    CAS  PubMed  Google Scholar 

  • Turner JD, Mand S, Debrah AY, Muehlfeld J, Pfarr K, McGarry HF et al (2006) A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection. Clin Infect Dis 42:1081–1089

    CAS  PubMed  Google Scholar 

  • Twum-Danso NA, Meredith SE (2003) Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis. Trop Med Int Health 8:820–831

    PubMed  Google Scholar 

  • Van Hoegaerden M, Ivanoff B, Flocard F, Salle A, Chabaud B (1987) The use of mebendazole in the treatment of filariases due to Loa loa and Mansonella perstans. Ann Trop Med Parasitol 81:275–282

    PubMed  Google Scholar 

  • Volkmann L, Saeftel M, Bain O, Fischer K, Fleischer B, Hoerauf A (2001) Interleukin-4 is essential for the control of microfilariae in murine infection with the filaria Litomosoides sigmodontis. Infect Immun 69:2950–2956

    CAS  PubMed Central  PubMed  Google Scholar 

  • Volkmann L, Bain O, Saeftel M, Specht S, Fischer K, Brombacher F et al (2003) Murine filariasis: interleukin 4 and interleukin 5 lead to containment of different worm developmental stages. Med Microbiol Immunol (Berl) 192:23–31

    CAS  Google Scholar 

  • Wammes LJ, Hamid F, Wiria AE, de Gier B, Sartono E, Maizels RM et al (2010) Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum. Eur J Immunol 40:437–442

    CAS  PubMed  Google Scholar 

  • Wanji S, Tendongfor N, Esum ME, Enyong P (2002) Chrysops silacea biting densities and transmission potential in an endemic area of human loiasis in south-west Cameroon. Trop Med Int Health 7:371–377

    PubMed  Google Scholar 

  • Ward DJ, Nutman TB, Zea-Flores G, Portocarrero C, Lujan A, Ottesen EA (1988) Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals. J Infect Dis 157:536–543

    CAS  PubMed  Google Scholar 

  • Weil GJ, Steel C, Liftis F, Li BW, Mearns G, Lobos E et al (2000) A rapid-format antibody card test for diagnosis of onchocerciasis. J Infect Dis 182:1796–1799

    CAS  PubMed  Google Scholar 

  • WHO (2010) Global programme to eliminate lymphatic filariasis (GPELF). Progress report 2000–2009 and strategic plan 2010–2020, 1–79

    Google Scholar 

  • WHO (2011) WHO: African Programme for Onchocerciasis Control: meeting of national task forces, September 2011. Geneva: World Health Organization; Weekly epidemiological record 2011: 541–556

    Google Scholar 

  • WHO (2012a) Provisional strategy for interrupting lymphatic filariasis transmission in loiasis-endemic countries. Report of the meeting on lymphatic filariasis, malaria and integrated vector management. Accra, Ghana, 5–9 March 2012. WHO/HTM/NTD/PCT/2012.6

    Google Scholar 

  • WHO (2012b) WHO: Global programme to eliminate lymphatic filariasis: progress report, 2011; Weekly epidemiological record, No. 37, 14 september 2012. Geneva: World Health Organization; Weekly epidemiological record 2011: 541–556

    Google Scholar 

  • Wildenburg G, Korten S, Buttner DW (1998) Mast cell distribution in nodules of Onchocerca volvulus from untreated patients with generalized onchocerciasis. Parasitology 116:257–268

    PubMed  Google Scholar 

  • Winkler S, Willheim M, Baier K, Aichelburg A, Kremsner PG, Graninger W (1999) Increased frequency of Th2-type cytokine-producing T cells in microfilaremic loiasis. Am J Trop Med Hyg 60:680–686

    CAS  PubMed  Google Scholar 

  • Wiseman RA (1967) Acanthocheilonema perstans, a cause of significant eosinophilia in the tropics: comments on its pathogenicity. Trans R Soc Trop Med Hyg 61:667–673

    CAS  PubMed  Google Scholar 

  • Zoure HG, Wanji S, Noma M, Amazigo UV, Diggle PJ, Tekle AH et al (2011) The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA). PLoS Negl Trop Dis 5:e1210

    PubMed Central  PubMed  Google Scholar 

  • Zuidema PJ (1971) Renal changes in loiasis. Folia Med Neerl 14:168–172

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr. Sabine Specht for critical reading of this chapter and for providing the two images of histological sections that are displayed in Fig. 12.3c, d. Further, we’d like to thank Constanze Kühn for her support with the life-cycle figure. This work was funded by the European Commission: Enhanced Protective Immunity Against Filariasis (EPIAF), agreement number 242131, by the projects from the German Research Foundation (HU 2144/1-1, HO 2009/8-1, HO 2009/10-1), intramural funding by the University Hospital Bonn (BONFOR, 2010-1-16 and 2011-1-10), and the People Programme (Marie Curie Actions) of the European Union’s Seventh Framework Programme FP7/2007–2013 under Research Executive Agency Grant GA 276704. AH is a member of the Excellence Cluster Immunosensation (DFG, EXC 1023).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Achim Hoerauf .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Wien

About this chapter

Cite this chapter

Hübner, M.P., Layland, L.E., Hoerauf, A. (2014). Lymphatic and Tissue Filariasis. In: Bruschi, F. (eds) Helminth Infections and their Impact on Global Public Health. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1782-8_12

Download citation

Publish with us

Policies and ethics